Nisa Investment Advisors LLC Sells 66,610 Shares of Kenvue Inc. $KVUE

Nisa Investment Advisors LLC lessened its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 29.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 158,632 shares of the company’s stock after selling 66,610 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Kenvue were worth $2,575,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the business. AlphaCore Capital LLC lifted its position in Kenvue by 9.9% in the 2nd quarter. AlphaCore Capital LLC now owns 5,287 shares of the company’s stock valued at $111,000 after acquiring an additional 476 shares in the last quarter. Empirical Finance LLC raised its stake in shares of Kenvue by 1.8% in the second quarter. Empirical Finance LLC now owns 28,309 shares of the company’s stock worth $593,000 after purchasing an additional 491 shares during the last quarter. Proffitt & Goodson Inc. lifted its holdings in shares of Kenvue by 8.2% in the second quarter. Proffitt & Goodson Inc. now owns 6,831 shares of the company’s stock valued at $143,000 after purchasing an additional 517 shares in the last quarter. UMB Bank n.a. boosted its position in shares of Kenvue by 22.3% during the second quarter. UMB Bank n.a. now owns 2,853 shares of the company’s stock valued at $60,000 after buying an additional 521 shares during the last quarter. Finally, Altus Wealth Group LLC grew its holdings in Kenvue by 1.7% during the second quarter. Altus Wealth Group LLC now owns 31,398 shares of the company’s stock worth $657,000 after buying an additional 524 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Kenvue

In other Kenvue news, Director Jeffrey C. Smith purchased 3,200,000 shares of the stock in a transaction dated Friday, December 12th. The shares were bought at an average price of $17.37 per share, with a total value of $55,584,000.00. Following the completion of the transaction, the director directly owned 27,307,632 shares in the company, valued at approximately $474,333,567.84. This trade represents a 13.27% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.17% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Weiss Ratings restated a “hold (c-)” rating on shares of Kenvue in a research note on Friday. Jefferies Financial Group cut their price target on shares of Kenvue from $25.00 to $23.00 and set a “buy” rating on the stock in a report on Monday, October 27th. UBS Group decreased their price objective on shares of Kenvue from $23.00 to $17.00 and set a “neutral” rating for the company in a research note on Wednesday, October 8th. Rothschild Redb raised Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, September 26th. Finally, Redburn Partners set a $22.00 price target on Kenvue in a report on Friday, September 26th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and twelve have assigned a Hold rating to the stock. According to MarketBeat, Kenvue currently has an average rating of “Hold” and an average price target of $20.23.

Kenvue Trading Up 0.2%

Shares of KVUE stock opened at $17.03 on Wednesday. The company has a quick ratio of 0.69, a current ratio of 0.98 and a debt-to-equity ratio of 0.66. The firm has a market cap of $32.62 billion, a P/E ratio of 22.70 and a beta of 0.60. The company has a 50 day moving average of $16.93 and a 200-day moving average of $18.33. Kenvue Inc. has a 12-month low of $14.02 and a 12-month high of $25.17.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.01. The business had revenue of $3.76 billion during the quarter, compared to analyst estimates of $3.83 billion. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.Kenvue’s revenue was down 3.5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.28 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Sell-side analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, November 26th. Shareholders of record on Wednesday, November 12th were given a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a yield of 4.9%. The ex-dividend date was Wednesday, November 12th. Kenvue’s dividend payout ratio (DPR) is currently 110.67%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.